The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms.
Autor(a) principal: | |
---|---|
Data de Publicação: | 1998 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243 |
Resumo: | We present six cases of superior vena cava syndrome caused by a malignant tumor that were treated by percutaneous endoprostheses. The technique is described and the results evaluated. In one case there was acute thrombosis of the endoprosthesis that was treated by urokinase. No other complications were observed. A patient died one month later due to progression of the tumor. The remaining cases were asymptomatic for longer than 6 months. It was concluded that endoprostheses for superior vena cava syndrome are efficient, with quick improvement of the symptomatology. |
id |
RCAP_ea0be6642ddb3250a29b385dd28beab6 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/2243 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms.A Utilização de Endopróteses na Síndrome da Veia Cava Superior por Neoplasia do Pulmão.We present six cases of superior vena cava syndrome caused by a malignant tumor that were treated by percutaneous endoprostheses. The technique is described and the results evaluated. In one case there was acute thrombosis of the endoprosthesis that was treated by urokinase. No other complications were observed. A patient died one month later due to progression of the tumor. The remaining cases were asymptomatic for longer than 6 months. It was concluded that endoprostheses for superior vena cava syndrome are efficient, with quick improvement of the symptomatology.We present six cases of superior vena cava syndrome caused by a malignant tumor that were treated by percutaneous endoprostheses. The technique is described and the results evaluated. In one case there was acute thrombosis of the endoprosthesis that was treated by urokinase. No other complications were observed. A patient died one month later due to progression of the tumor. The remaining cases were asymptomatic for longer than 6 months. It was concluded that endoprostheses for superior vena cava syndrome are efficient, with quick improvement of the symptomatology.Ordem dos Médicos1998-04-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243oai:ojs.www.actamedicaportuguesa.com:article/2243Acta Médica Portuguesa; Vol. 11 No. 4 (1998): Abril; 331-6Acta Médica Portuguesa; Vol. 11 N.º 4 (1998): Abril; 331-61646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243/1662Pisco, J MNobre, IFernandes, OGarcia, VMartins, J MDuarte, A CFreitas, M Ginfo:eu-repo/semantics/openAccess2022-12-20T11:00:06Zoai:ojs.www.actamedicaportuguesa.com:article/2243Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:37.016324Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. A Utilização de Endopróteses na Síndrome da Veia Cava Superior por Neoplasia do Pulmão. |
title |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. |
spellingShingle |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. Pisco, J M |
title_short |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. |
title_full |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. |
title_fullStr |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. |
title_full_unstemmed |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. |
title_sort |
The use of endoprosthesis in superior vena cava syndrome caused by lung neoplasms. |
author |
Pisco, J M |
author_facet |
Pisco, J M Nobre, I Fernandes, O Garcia, V Martins, J M Duarte, A C Freitas, M G |
author_role |
author |
author2 |
Nobre, I Fernandes, O Garcia, V Martins, J M Duarte, A C Freitas, M G |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Pisco, J M Nobre, I Fernandes, O Garcia, V Martins, J M Duarte, A C Freitas, M G |
description |
We present six cases of superior vena cava syndrome caused by a malignant tumor that were treated by percutaneous endoprostheses. The technique is described and the results evaluated. In one case there was acute thrombosis of the endoprosthesis that was treated by urokinase. No other complications were observed. A patient died one month later due to progression of the tumor. The remaining cases were asymptomatic for longer than 6 months. It was concluded that endoprostheses for superior vena cava syndrome are efficient, with quick improvement of the symptomatology. |
publishDate |
1998 |
dc.date.none.fl_str_mv |
1998-04-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243 oai:ojs.www.actamedicaportuguesa.com:article/2243 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/2243 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2243/1662 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 11 No. 4 (1998): Abril; 331-6 Acta Médica Portuguesa; Vol. 11 N.º 4 (1998): Abril; 331-6 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130629266210816 |